Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript
Teva Reports Significant Prevention Of Gluten-Induced Damage in New Study - Teva Pharmaceutical Indus (NY
Teva Stock Rises After TEV '408 Meets Primary Endpoint in Celiac Disease Study - Teva Pharmaceutical Indu
Trump Expands Drug Pricing Agreements With 9 Drugmakers— RFK Jr. Says President Called ‘Every Hour’ to En
BioXcel Stock Plunges: Chapter 11 Filing Triggers Teva Stalking Horse Bid - Teva Pharmaceutical Indus (NY